1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Visualization Instruments for MIS Market
4. Market Overview
    4.1. Overview
    4.2. Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Opportunities
    4.3. Global Visualization Instruments for MIS Market Value Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Technological Advancements
    5.2. Key Industry Events
    5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Visualization Instruments for MIS Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Visualization Systems
            6.3.1.1. 2D Systems
            6.3.1.2. 3D Systems
        6.3.2. Consumables & Accessories
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Visualization Instruments for MIS Market Analysis and Forecast, by MIS Type
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by MIS Type, 2017–2031
        7.3.1. Endoscopy
            7.3.1.1. Arthroscopy
            7.3.1.2. Laparoscopy
            7.3.1.3. Obstetrics & Gynecology Endoscopy
            7.3.1.4. Urologic Endoscopy
            7.3.1.5. Bronchoscopy
            7.3.1.6. Gastroscopy
            7.3.1.7. Others
        7.3.2. Robotic Surgery
    7.4. Market Attractiveness Analysis, by MIS Type
8. Global Visualization Instruments for MIS Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Clinics
        8.3.3. Ambulatory Surgery Centers
        8.3.4. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Visualization Instruments for MIS Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Visualization Instruments for MIS Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017–2031
        10.2.1. Visualization Systems
            10.2.1.1. 2D Systems
            10.2.1.2. 3D Systems
        10.2.2. Consumables & Accessories
    10.3. Market Value Forecast, by MIS Type, 2017–2031
        10.3.1. Endoscopy
            10.3.1.1. Arthroscopy
            10.3.1.2. Laparoscopy
            10.3.1.3. Obstetrics & Gynecology Endoscopy
            10.3.1.4. Urologic Endoscopy
            10.3.1.5. Bronchoscopy
            10.3.1.6. Gastroscopy
            10.3.1.7. Others
        10.3.2. Robotic Surgery
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Clinics
        10.4.3. Ambulatory Surgery Centers
        10.4.4. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product Type
        10.6.2. By MIS Type
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Visualization Instruments for MIS Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Visualization Systems
            11.2.1.1. 2D Systems
            11.2.1.2. 3D Systems
        11.2.2. Consumables & Accessories
    11.3. Market Value Forecast, by MIS Type, 2017–2031
        11.3.1. Endoscopy
            11.3.1.1. Arthroscopy
            11.3.1.2. Laparoscopy
            11.3.1.3. Obstetrics & Gynecology Endoscopy
            11.3.1.4. Urologic Endoscopy
            11.3.1.5. Bronchoscopy
            11.3.1.6. Gastroscopy
            11.3.1.7. Others
        11.3.2. Robotic Surgery
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Clinics
        11.4.3. Ambulatory Surgery Centers
        11.4.4. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product Type
        11.6.2. By MIS Type
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Visualization Instruments for MIS Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Visualization Systems
            12.2.1.1. 2D Systems
            12.2.1.2. 3D Systems
        12.2.2. Consumables & Accessories
    12.3. Market Value Forecast, by MIS Type, 2017–2031
        12.3.1. Endoscopy
            12.3.1.1. Arthroscopy
            12.3.1.2. Laparoscopy
            12.3.1.3. Obstetrics & Gynecology Endoscopy
            12.3.1.4. Urologic Endoscopy
            12.3.1.5. Bronchoscopy
            12.3.1.6. Gastroscopy
            12.3.1.7. Others
        12.3.2. Robotic Surgery
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Clinics
        12.4.3. Ambulatory Surgery Centers
        12.4.4. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product Type
        12.6.2. By MIS Type
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Visualization Instruments for MIS Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Visualization Systems
            13.2.1.1. 2D Systems
            13.2.1.2. 3D Systems
        13.2.2. Consumables & Accessories
    13.3. Market Value Forecast, by MIS Type, 2017–2031
        13.3.1. Endoscopy
            13.3.1.1. Arthroscopy
            13.3.1.2. Laparoscopy
            13.3.1.3. Obstetrics & Gynecology Endoscopy
            13.3.1.4. Urologic Endoscopy
            13.3.1.5. Bronchoscopy
            13.3.1.6. Gastroscopy
            13.3.1.7. Others
        13.3.2. Robotic Surgery
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Clinics
        13.4.3. Ambulatory Surgery Centers
        13.4.4. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product Type
        13.6.2. By MIS Type
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Visualization Instruments for MIS Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017–2031
        14.2.1. Visualization Systems
            14.2.1.1. 2D Systems
            14.2.1.2. 3D Systems
        14.2.2. Consumables & Accessories
    14.3. Market Value Forecast, by MIS Type, 2017–2031
        14.3.1. Endoscopy
            14.3.1.1. Arthroscopy
            14.3.1.2. Laparoscopy
            14.3.1.3. Obstetrics & Gynecology Endoscopy
            14.3.1.4. Urologic Endoscopy
            14.3.1.5. Bronchoscopy
            14.3.1.6. Gastroscopy
            14.3.1.7. Others
        14.3.2. Robotic Surgery
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Clinics
        14.4.3. Ambulatory Surgery Centers
        14.4.4. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product Type
        14.6.2. By MIS Type
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company, 2021
    15.3. Company Profiles
        15.3.1. Arthrex GmbH
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Product Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. B. Braun Melsungen AG
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Product Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. CONMED Corporation
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Product Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. Medtronic plc
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Product Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. Millennium Surgical Corp
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Strategic Overview
            15.3.5.5. Strategic Overview
        15.3.6. Richard Wolf GmbH
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Product Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. Lazurite Holdings LLC
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Product Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. Smith & Nephew plc
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Product Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview
        15.3.9. Stryker Corporation
            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.9.2. Product Portfolio
            15.3.9.3. Product Portfolio
            15.3.9.4. SWOT Analysis
            15.3.9.5. Strategic Overview
        15.3.10. Olympus Corporation
            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.10.2. Product Portfolio
            15.3.10.3. Financial Overview
            15.3.10.4. SWOT Analysis
            15.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			